Influenza
Showing NaN - NaN of 70
Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (Standard Dose Quadrivalent Inactivated
Not yet recruiting
- Immunization; Infection
- +2 more
- Standard Dose Quadrivalent Inactivated Influenza Vaccine
- High Dose Quadrivalent Inactivated Influenza Vaccine
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 11, 2023
Influenza Trial in Worldwide (Baloxavir Marboxil, Placebo)
Recruiting
- Influenza
- Baloxavir Marboxil
- Placebo
-
Birmingham, Alabama
- +290 more
Jan 20, 2023
Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (High Dose Quadrivalent Inactivated Influenza
Recruiting
- Immunization; Infection
- +3 more
- High Dose Quadrivalent Inactivated Influenza Vaccine
- Standard Dose Quadrivalent Inactivated Influenza Vaccine
-
Nashville, TennesseeVanderbilt Univeristy Medical Center
May 27, 2022
Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (High Dose Quadrivalent Inactivated Influenza
Not yet recruiting
- Immunization; Infection
- +2 more
- High Dose Quadrivalent Inactivated Influenza Vaccine
- Standard Dose Quadrivalent Inactivated Influenza Vaccine
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 21, 2022
Avian Influenza, H1N1 Influenza, Influenza Trial in Nashville (AS03, Influenza Virus Vaccine, Monovalent A/H3N2v
Completed
- Avian Influenza
- +2 more
- AS03
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center - Vanderbilt Institute for
Jan 25, 2022
Influenza, Influenza Immunisation Trial in United States (AF03, Delta Inulin-CpG55.2, Influenza Virus Quadrivalent Inactivated
Influenza Trial in Worldwide (Liquid CAIV-T)
Completed
- Influenza
- Liquid CAIV-T
-
Hoover, Alabama
- +160 more
Sep 10, 2021
Asthma in Children, Vaccine Adverse Reaction, Vaccine Reaction Trial in Durham, Cincinnati, Nashville (Live Attenuated Influenza
Completed
- Asthma in Children
- +5 more
- Live Attenuated Influenza Vaccine (LAIV)
- Inactivated Influenza Vaccine (IIV)
-
Durham, North Carolina
- +2 more
Feb 25, 2021
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine
Completed
- Pregnancy
- Influenza
- Quadrivalent Intradermal Influenza Vaccine (QIV)
-
San Diego, California
- +4 more
Feb 11, 2020
Pregnancy, Influenza Trial in United States (Quadrivalent Influenza Vaccine (QIV))
Completed
- Pregnancy
- Influenza
- Quadrivalent Influenza Vaccine (QIV)
-
San Diego, California
- +4 more
Feb 11, 2020
Influenza Trial in Nashville (ASO3 Adjuvant, Influenza A/H5N1 Vaccine)
Completed
- Influenza
- ASO3 Adjuvant
- Influenza A/H5N1 Vaccine
-
Nashville, TennesseeVanderbilt University - Pediatric - Vanderbilt Vaccine Research
Oct 18, 2019
Inactivated Influenza Vaccine in Healthy Adults
Completed
- Influenza
- +6 more
- Influenza Vaccine Recipients
-
Nashville, TennesseeVanderbilt University Medical Center
Aug 2, 2019
Influenza Trial in Worldwide (Amantadine, Ribavirin, Oseltamivir, Oseltamivir)
Completed
- Influenza
- Amantadine, Ribavirin, Oseltamivir
- Oseltamivir
-
Birmingham, Alabama
- +90 more
Jan 31, 2019
Influenza Trial in United States (Seasonal Influenza DNA vaccine, TIV)
Completed
- Influenza
- Seasonal Influenza DNA vaccine
- TIV
-
Atlanta, Georgia
- +4 more
Dec 4, 2018
Influenza Trial in Worldwide (Influenza vaccine GSK2321138A, FluarixTM, Influenza vaccine GSK2604409A)
Completed
- Influenza
- Influenza vaccine GSK2321138A
- +2 more
-
Chandler, Arizona
- +41 more
Aug 22, 2018
Influenza Trial in Canada, United States (Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, Placebo)
Completed
- Influenza
- Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
- Placebo
-
Huntsville, Alabama
- +39 more
May 9, 2018
Influenza Trial in Worldwide (Influsplit Tetra™ vaccine produced by investigational process (IP), Influsplit Tetra™ vaccine
Completed
- Influenza
- Influsplit Tetra™ vaccine produced by investigational process (IP)
- Influsplit Tetra™ vaccine produced by licensed process (LP)
-
Wichita, Kansas
- +52 more
May 31, 2018
Influenza Trial in Worldwide (40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate, Placebo)
Completed
- Influenza
- 40 mg Laninamivir Octanoate
- +2 more
-
Scottsboro, Alabama
- +220 more
May 29, 2018
Influenza Trial in United States (CSL Limited Influenza Virus Vaccine (Afluria®), US Licensed Influenza Virus Vaccine
Completed
- Influenza
- CSL Limited Influenza Virus Vaccine (Afluria®)
- US Licensed Influenza Virus Vaccine (Fluzone®)
-
Mountain Home, Arkansas
- +12 more
Apr 25, 2018
Influenza Trial in United States (High-dose quadrivalent influenza virus vaccine, High-dose influenza virus vaccine, High-dose
Completed
- Influenza
- High-dose quadrivalent influenza virus vaccine
- +2 more
-
Milford, Connecticut
- +8 more
Feb 5, 2018